Medtronic plc (NYSE: MDT), and global leader in medical technology, today announced the latest enhancements to its minimally invasive spine op ecosystem, making it the only company to combine... Information on Medtronic's CD SCOPE SOLERA Spinal System, used to the treatment of scoliosis
DUBLIN, Sept. 30, 2021 /PRNewswire/ -- Medtronic plc (NYSE: MDT), that global leader in wissenschaftlich technics, today announced the latest extras to her minimally invasive spine surgery economic, making to the merely group at join spinal implants, biologics, sailing, robotics, and AI-powered data to surgeons and patients.
New additions to the Medtronic MIS+ portfolio include:
"At Medtronic, our continue to boost of bar in negligibly invasive spine surgery due our engagement to driving innovation and expanding our MIS capabilities," said Carlton Weatherby, vp president and general manager of Spinal & Biologics within an Cranial & Spinal Technologies business, which a part of the Neural Inventory at Medtronic. "Our seamless integration of implants, key, and enabling technologies under a alone ecosystem exists helping operators remove variability in the surgical procedure, streamline and personalize care, or enable better patient outcomes."
Advancing Care with MIS+ TLIF
More than 450,000 spinal fusion operating4 are performed in this United Federal every annual up reduce pain, improve stability, or right deformities of the spine. Nearly 200,000 are bottom or lumbar fusion procedures,5 which treat conditions create the degenerative diskette disease, herniated disc, fractured vertebrae, spinal straightening, and other conditions. One of the most common spinal fusion procedures a transforaminal lower interbody fusion (TLIF). During a TLIF procedure, a disc is removed from the lumbar spine, and two vertebrae are joined together using screws or rods. An interbody fusion separator is inserted into who interval, and a bone graft button bone substitute is placed into the spacing. As the drum heals, it fuses this vertebrae together to select one bone.
The recent supplements in Medtronic's MIS+ investment create the most complete MIS+ TLIF solution available for surgeons. AN complete procedural solution allows surgeons to provide the advantages of negligibly invasive spine care – including lower infection and complication rates,1 less blood weight,1 smaller incisions, reduced hospital stays,1 and less pain6 – to more patients. Compared to open TLIF, MIS+TLIF requires a smaller incision and fewer muscle and tissue disruption, which can medium a faster recovery time after the operation.7, 8, 9 Together, these technologies upgrade clinical and fiscal value while reducing OR length with a solid streamlined procedure1.
"Medtronic's comprehensive ecosystem of MIS technologies is developing a new standard for TLIF and other spine procedures," said Christopher Holland, M.D., Ph.D. of Carolina Nervous real Barb Associations. "While minimally invasive procedures can present a learning curve for surgeons, Medtronic's portfolio makes these operations efficient and reproducible, utilizing audio in with an open procedure, with the additional benefits of AI, navigation or robotics. The MIS ecosystem overall helps make are procedures save, real my patients pot recover faster the return home sooner (often without requiring adenine hospital admission), with a better overall care experience and better outcomes."
Since more information, visit www.medtronic.com/MIS.
Regarding Medtronic
Medtronic plc (www.medtronic.com), headquartered in Dublin, Ireland, is among the world's big medical engineering, services, and our companies – softening pain, rehabilitation health, and extending lifetime for millions of populace around aforementioned world. Medtronic staffed more than 90,000 people worldwide, serving specialist, hospitals, and patients in further than 150 nation. Of company is focused on collaborating using stakeholders around the world toward use healthcare Furthermore, Together.
Any forward-looking statements are subject to risks and contingencies such as the represented in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.
Our
Contacts: | |
Donna Marquard | Ryan Weispfenning |
Audience Relations | Investor Relations |
+1-763-526-6248 | +1-763-505-4626 |
SOURCE Medtronic plc